<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJO</journal-id><journal-title-group><journal-title>Open Journal of Orthopedics</journal-title></journal-title-group><issn pub-type="epub">2164-3008</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojo.2017.71002</article-id><article-id pub-id-type="publisher-id">OJO-73697</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Primary Alveolar Soft Part Sarcoma of the Scapula
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ghada</surname><given-names>Sahraoui</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nadia</surname><given-names>Boujelbene</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Raoudha</surname><given-names>Doghri</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Karima</surname><given-names>Mrad</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Pathology, Salah Azaiez Institute, Tunis, Tunisia</addr-line></aff><pub-date pub-type="epub"><day>13</day><month>01</month><year>2017</year></pub-date><volume>07</volume><issue>01</issue><fpage>7</fpage><lpage>13</lpage><history><date date-type="received"><day>December</day>	<month>8,</month>	<year>2016</year></date><date date-type="rev-recd"><day>Accepted:</day>	<month>January</month>	<year>19,</year>	</date><date date-type="accepted"><day>January</day>	<month>22,</month>	<year>2017</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Alveolar soft-part sarcoma (ASPS) is an uncommon, aggressive soft-tissue neoplasm, occurring in less than 1% of sarcomas. It is typically found in the head and neck tissues in children or in the deep soft tissues of the lower extremities in young adults. This tumor arises primarily within the skeletal muscles or musculofascial planes. Primary involvement of bone is extremely rare. ASPS has poor prognosis with a propensity for recurrence as well as distant metastasis. In this report, we present a 25-year-old male with primary ASPS in the left scapular bone and discuss the histopathological and immunohistochemical features of this sarcoma.
 
</p></abstract><kwd-group><kwd>Alveolar Soft-Part Sarcoma</kwd><kwd> Histopathological</kwd><kwd> Scapula</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Alveolar soft part sarcoma (ASPS) is rare, distinctive soft tissue sarcoma composed of large, uniform, epithelioid cells and characterized by ASPSCR1-TFE3 fusion gene [<xref ref-type="bibr" rid="scirp.73697-ref1">1</xref>] . It accounts for less than 1% of all soft tissue malignancies, and generally occurs between 15 and 35 years of age with a notable female predominance [<xref ref-type="bibr" rid="scirp.73697-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.73697-ref2">2</xref>] . ASPS usually presents as a slowly growing, painless mass [<xref ref-type="bibr" rid="scirp.73697-ref1">1</xref>] . Pediatric ASPS appears most commonly in the head and neck tissues, however, lower extremity involvement may be found in young adults [<xref ref-type="bibr" rid="scirp.73697-ref3">3</xref>] . Primary bone involvement is occasional, and characteristically involves the fibula, ileum and tibia [<xref ref-type="bibr" rid="scirp.73697-ref4">4</xref>] . Only 2 cases with primary involvement of the scapular bone have been reported previously in the literature [<xref ref-type="bibr" rid="scirp.73697-ref3">3</xref>] . This case highlights some of the histopathological pitfalls in the diagnosis of ASPS and the possible unusual site of presentation.</p></sec><sec id="s2"><title>2. Case Report</title><p>A 25-year-old male presented with a rapidly increasing swelling over the left scapular region of six months duration. Physical examination detected a 9.5 &#215; 9 cm sized scapular tumor fixed to the deep structures, but free from the overlying skin and a limited mobility of the left shoulder. Contrast-enhanced computed tomography (CT) of the left shoulder revealed a heterogeneous mass within the left scapula resulting in destruction of the bone cortex and local expansion to adjacent muscle, bone and joint structures. Magnetic resonance imaging (MRI) showed an osseous soft tissue mass with necrotic center originating in the left scapular region and involving the rotator cuff muscles and the gleno-humeral joint (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Thoracoabdominal CT showed metastatic lung, spleen and lymph node lesions.</p><p>Tru-Cut biopsy of the scapular lesion was performed. Microscopic exam showed cellular tumor arranged in a nesting or pseudoalveolar pattern of largerelatively uniformepithelioid cells with abundant eosinophilic granular cytoplasm and hyperchromatic vesicular nuclei having prominent nucleoli (<xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig3">Figure 3</xref>). There was a mitotic rate of 1per ten high power fields. According to these morphological features, both rhabdomyosarcoma and alveolar soft part sarcoma were suspected. Immunohistochemically, the tumor cells showed positive staining for Desmin (<xref ref-type="fig" rid="fig4">Figure 4</xref>) and a strong nuclear staining for TFE3 (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Staining for CD31, epithelial markers and myogenin were negative.</p><p>Morphological features and immunohistochemical stains were in favor of the diagnosis of ASPS.</p><p>Since the tumor was judged non-resectable by surgeons, the patient received palliative chemotherapy (Doxorubicin 106 mg/day; Ifosfamide 5 g the first day and 5, 6 g the second day; Mesna 6 g the first day and 7 g the second day) but</p><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> MRI of the left shoulder: hyperintense osseous soft tissue mass involving the rotator cuff muscles and the gleno-humeral joint</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/2-2010447x2.png"/></fig><fig id="fig2"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref></label><caption><title> Alveolar nests of tumor cells separated by thin fibrous septae</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/2-2010447x3.png"/></fig><fig id="fig3"  position="float"><label><xref ref-type="fig" rid="fig3">Figure 3</xref></label><caption><title> Epithelioid cells with abundant eosinophilic granular cytoplasm</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/2-2010447x4.png"/></fig><fig id="fig4"  position="float"><label><xref ref-type="fig" rid="fig4">Figure 4</xref></label><caption><title> Tumor cells express desmin</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/2-2010447x5.png"/></fig><fig id="fig5"  position="float"><label><xref ref-type="fig" rid="fig5">Figure 5</xref></label><caption><title> Strong nuclear staining for TFE3</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/2-2010447x6.png"/></fig><p>without any response. The metastatic lesions detected at the beginning of the explorations persisted and other cerebral and hepatic metastases had appeared. Another regimen of chemotherapy was proposed. However, the patient refused to complete the treatment and died seven months after the latest course of chemotherapy.</p></sec><sec id="s3"><title>3. Discussion</title><p>ASPS is a rare soft-tissue malignancy that was originally alluded to by Smetana and Scott as a malignant tumor of the non-chromaffin paraganglia in 1951 [<xref ref-type="bibr" rid="scirp.73697-ref5">5</xref>] , and then described under its present name of “alveolar soft-part sarcoma” by Christopherson et al. in 1952 [<xref ref-type="bibr" rid="scirp.73697-ref1">1</xref>] . It occurs, in less than 1% of sarcomas, usually in adolescents and young adults, with a female predominance [<xref ref-type="bibr" rid="scirp.73697-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.73697-ref6">6</xref>] . ASPS primarily arises from the deep soft tissue of the extremities, trunk, retroperitoneum, head and neck. In children, ASPS has an unusual tendency to involve the tongue and orbit [<xref ref-type="bibr" rid="scirp.73697-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.73697-ref8">8</xref>] . Other locations, such as the female genital tract [<xref ref-type="bibr" rid="scirp.73697-ref6">6</xref>] , mediastinum [<xref ref-type="bibr" rid="scirp.73697-ref9">9</xref>] , lung [<xref ref-type="bibr" rid="scirp.73697-ref10">10</xref>] , gastrointestinal tract, are rare [<xref ref-type="bibr" rid="scirp.73697-ref11">11</xref>] . Primary bone involvement is occasional [<xref ref-type="bibr" rid="scirp.73697-ref12">12</xref>] , and it characteristically involves the fibula, ileum and tibia [<xref ref-type="bibr" rid="scirp.73697-ref4">4</xref>] . Only 2 cases with primary involvement of the scapular bone have been previously reported in the literature [<xref ref-type="bibr" rid="scirp.73697-ref3">3</xref>] . Radiologic findings reported in these cases were similar to ours: ill-defined osteolytic lesions on plain radiographs and expansile bone tumor with large intra- and extraosseous soft tissue masses on CT [<xref ref-type="bibr" rid="scirp.73697-ref3">3</xref>] . Park and al. [<xref ref-type="bibr" rid="scirp.73697-ref13">13</xref>] described a common feature of all cases which is bone destruction with poorly defined tumor margins. The pathological diagnosis of ASPS is based on morphological features, including large, uniform, epithelioid cells with eosinophilic abundant granular cytoplasm arranged in solid nests and/or alveolar structures [<xref ref-type="bibr" rid="scirp.73697-ref14">14</xref>] . The distinctively organoid or nesting may be absent especially in children. The nests tend to be uniform but may vary in size and shape. Loss of cellular cohesion and necrosis of centrally located cells in the nests result in the commonly seen pseudoalveolar pattern. The neoplastic cells are generally uniform in size, round or polygonal, with well-defined borders conferring an epithelioid appearance. The nucleus is generally centrally placed, bland with prominent nucleolus. Multinucleation and nuclear atypia are uncommon. Mitotic figures are infrequent. The cytoplasm is abundant eosinophilic and granular but occasionally may exhibits some clear features that mimics renal clear cell carcinoma. The cytoplasm may also contain rhomboid or rod-shaped inclusions that can be faintly apparent in standard coloration but better demonstrated on periodic acid Schiff (PAS) stains after diastase digestion. In addition to that, vascular invasion is frequently seen. Morphologically, our tumor met all these criteria but PAS stains were negative.</p><p>Because of the young age of our patient, the clinical presentation and the histological aspect of the tumor, rhabdomyosarcoma was the first diagnostic evoked which justified the first panel of immunohistochemistry based on the antibodies Myogenin and Desmin. The negativity of myogenin prompted us to seek another diagnosis. Thanks to the positivity of the anti-TFE3 carried out in the second panel of immunohistochemistry, the exact diagnosis was made.</p><p>The most characteristic finding in ASPS is the consistent demonstration of strong nuclear immunoreactivity for TFE3, reflecting the ASPSCR1-TFE3 fusion gene that had been identified by cytogenetic analysis [<xref ref-type="bibr" rid="scirp.73697-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.73697-ref14">14</xref>] . Recent studies have shown that the crystals are immunoreactive to a protein MCT1 (monocarboxylate transporter) and to CD 147 [<xref ref-type="bibr" rid="scirp.73697-ref15">15</xref>] . About 50% of ASPS tumors express Desmin, as our case showed. Staining for protein S100 can be positive. Generally, epithelial, melanocytic, neural, glial, and neuroendocrine markers are negative [<xref ref-type="bibr" rid="scirp.73697-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.73697-ref16">16</xref>] .</p><p>The differential diagnosis of ASPS [<xref ref-type="bibr" rid="scirp.73697-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.73697-ref17">17</xref>] involves a wide range of neoplasms that contain a similar alveolar nest-like pattern. This includes renal, adrenal and hepatocellular carcinomas, which have a similar eosinophilic cytoplasm, but are distinguished by cytokeratin markers.</p><p>Melanoma can be differentiated by PAS negativity and positivity for melanocyticmarkers. Unlike ASPS, extra adrenal paragangliomas show strong expression of neuroendocrine markers and S100 typically is positive in the sustentacular cells. Granular cell tumors are strongly positive for S100, and lack the characteristic vascularization of ASPS.</p><p>Due to the alveolar architecture and occasional staining for muscle markers, a diagnosis of alveolar rhabdomyosarcoma may be considered, however, the cytology of ASPS is larger and with more abundant cytoplasm than seen in alveolar rhabdomyosarcomas. While both are highly vascularized tumors, the differentiation of ASPS from hemangioendothelioma is not commonly a diagnostic dilemma. Renal cell carcinoma occasionally mimics ASPS, but often shows focal tubular pattern of growth and lacks the crystals.</p><p>It is reported that ASPS is an indolent disease with characteristic slow growth, but that is associated with a poor overall outcome and a 5-year survival rate of only 20% in unresectable metastatic patients [<xref ref-type="bibr" rid="scirp.73697-ref18">18</xref>] . Unlike the rare cases described in the literature where patients have undergone surgical treatment and been relatively improved after treatment [<xref ref-type="bibr" rid="scirp.73697-ref3">3</xref>] , our patient had rapidly fatal outcome.</p><p>Metastasis can occur early sometimes before primary lesion detection or later after tumor resection even without local recurrence [<xref ref-type="bibr" rid="scirp.73697-ref14">14</xref>] . The most common sites of metastases are, in decreasing order of frequency, lung, bone and brain [<xref ref-type="bibr" rid="scirp.73697-ref14">14</xref>] . Metastases to the lymph nodes are not frequent [<xref ref-type="bibr" rid="scirp.73697-ref14">14</xref>] . Prognostic factors are age at presentation, tumor size and the presence of metastasisat diagnosis [<xref ref-type="bibr" rid="scirp.73697-ref14">14</xref>] . Tumor size correlates with metastatic disease at onset and is the major factor influencing survival [<xref ref-type="bibr" rid="scirp.73697-ref19">19</xref>] .</p><p>Surgical excision remains the mainstay of therapy, and adjuvant chemotherapy and radiotherapy have no definite role in its management [<xref ref-type="bibr" rid="scirp.73697-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.73697-ref19">19</xref>] . In the present case the tumor was found to be infiltrating adjacent muscles therefore judged inoperable. The patient received adjuvant chemotherapy and continues to be on follow up.</p></sec><sec id="s4"><title>5. Conclusion</title><p>In conclusion, this case is presented to highlight the distinctive clinical, morphological and immunohistochemical features of this unusual tumor. ASPS should be taken into consideration in the differential diagnosis of bone-originating soft tissue masses. Characteristic features of the lesion contribute to differentiating this entity from other bone tumors, primitive or metastatic.</p></sec><sec id="s5"><title>Cite this paper</title><p>Sahraoui, G., Boujelbene, N., Doghri, R. and Mrad, K. (2017) Primary Alveolar Soft Part Sarcoma of the Scapula. Open Journal of Orthopedics, 7, 7-13. http://dx.doi.org/10.4236/ojo.2017.71002</p></sec></body><back><ref-list><title>References</title><ref id="scirp.73697-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Christopherson, W.M., Foote, F.W. and Stewart, F.W. (1952) Alveolar Soft-Part Sarcomas; Structurally Characteristic Tumors of Uncertain Histogenesis. Cancer, 5, 100-111.  
https://doi.org/10.1002/1097-0142(195201)5:1&lt;100::AID-CNCR2820050112&gt;3.0.CO;2-K</mixed-citation></ref><ref id="scirp.73697-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Chen, Z., Chengtao, S., Wei, S., et al. (2016) Alveolar Soft-Part Sarcoma in the Left Forearm with Cardiac Metastasis: A Case Report and Literature Review. Oncology Letters, 11, 81-84.</mixed-citation></ref><ref id="scirp.73697-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Yavuz, A., Cemil, G., Aydin, B. and Mehmet, B. (2013) Primary Alveolar Soft Part Sarcoma of the Scapula. Case Reports in Oncology, 6, 356-361.  
https://doi.org/10.1159/000353927</mixed-citation></ref><ref id="scirp.73697-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">James, A.W., Chang, L., Levine, B. and Dry, S.M. (2014) Clavicular and Meningeal Alveolar Soft Part Sarcoma: An Unusual Case and Literature Review. Journal of Orthopaedics, 11, 48-53. https://doi.org/10.1016/j.jor.2013.12.014</mixed-citation></ref><ref id="scirp.73697-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Smetana, H.F. and Scott, W.F. (1951) Malignant Tumors of Nonchromaffin Paraganglia. Military Surgeon, 109, 330-349.</mixed-citation></ref><ref id="scirp.73697-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, L., Tang, Q., Wang, Z. and Zhang, X. (2012) Alveolar Soft Part Sarcoma of the Uterine Corpus with Pelvic Lymph Node Metastasis: Case Report and Literature Review. International Journal of Clinical and Experimental Pathology, 5, 715-719.</mixed-citation></ref><ref id="scirp.73697-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Fanburg-Smith, J.C., Miettinen, M., Folpe, A.L., Weiss, S.W. and Childers, E.L.B. (2004) Lingual Alveolar Soft Part Sarcoma; 14 Cases: Novel Clinical and Morphological Observations. Histopathology, 45, 526-537.  
https://doi.org/10.1111/j.1365-2559.2004.01966.x</mixed-citation></ref><ref id="scirp.73697-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Font, R.L., Jurco, S. and Zimmerman, L.E. (1982) Alveolar Soft-Part Sarcoma of the Orbit: A Clinicopathologic Analysis of Seventeen Cases and a Review of the Literature. Human Pathology, 13, 569-579.  
https://doi.org/10.1016/S0046-8177(82)80273-6</mixed-citation></ref><ref id="scirp.73697-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Flieder, D.B., Moran, C.A. and Suster, S. (1997) Primary Alveolar soft-Part Sarcoma of the Mediastinum: A Clinicopathological and Immunohistochemical Study of Two Cases. Histopathology, 31, 46-73.  
https://doi.org/10.1046/j.1365-2559.1997.2690871.x</mixed-citation></ref><ref id="scirp.73697-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Trabelsi, A., Ben Abdelkrim, S., Taher, Y.M., Mlika, S., Hmissa, S., Mokni, M., et al. (2009) Primary Alveolar Soft Part Sarcoma of the Lung. Revue des Maladies Respiratoires, 26, 329-332. https://doi.org/10.1016/S0761-8425(09)72591-4</mixed-citation></ref><ref id="scirp.73697-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Yaziji, H., Ranaldi, R., Verdolini, R., Morroni, M., Haggitt, R. and Bearzi, I. (2000) Primary Alveolar Soft Part Sarcoma of the Stomach: A Case Report and Review. Pathology-Research and Practic, 196, 519-525.  
https://doi.org/10.1016/S0344-0338(00)80054-0</mixed-citation></ref><ref id="scirp.73697-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Das, K.K., Singh, R.K., Jaiswal, S., Agrawal, V., Jaiswal, A.K. and Behari, S. (2012) Alveolar Soft Part Sarcoma of the Frontal Calvarium and Adjacent Frontal Lobe. Journal of Pediatric Neurosciences, 7, 36-39.  
https://doi.org/10.4103/1817-1745.97621</mixed-citation></ref><ref id="scirp.73697-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Park, Y.K., Unni, K.K., Kim, Y.W., Han, C.S., Yang, M.H., Wenger, D.E., et al. (1999) Primary Alveolar Soft Part Sarcoma of Bone. Histopathology, 35, 411-417.  
https://doi.org/10.1046/j.1365-2559.1999.035005411.x</mixed-citation></ref><ref id="scirp.73697-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Ordónez, N.G. (2013) Alveolar Soft Part Sarcoma. In: Fletcher, C.D.M., World Health Organization Classification of Tumours of Soft Tissues and Bone, IARC Press, Lyon, 218-221.</mixed-citation></ref><ref id="scirp.73697-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Weiss, S.W. (2002) Alveolar Soft Part Sarcoma: Are We at the End or Just the Beginning of Our Quest? The American Journal of Pathology, 160, 1197-1199.  
https://doi.org/10.1016/S0002-9440(10)62545-X</mixed-citation></ref><ref id="scirp.73697-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Aluigi, P., Sangiorgi, L. and Picci, P. (1996) Alveolar Soft Part Sarcoma. Skeletal Radiology, 25, 400-402. https://doi.org/10.1007/s002560050104</mixed-citation></ref><ref id="scirp.73697-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Nair, A., Pai, D.R., Jagdish, S. and Krishnan, R. (2003) Alveolar Soft Part Sarcoma: A Unique Tumor with Disputed Histogenesis. Indian Journal of Cancer, 40, 82.</mixed-citation></ref><ref id="scirp.73697-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Shivaani, K, Deborah, A. and Helman, L. (2013) Cediranib for Metastatic Alveolar Soft Part Sarcoma. Journal of Clinical Oncology, 31, 2296-2302.  
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677840/  
https://doi.org/10.1200/JCO.2012.47.4288</mixed-citation></ref><ref id="scirp.73697-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Casanova, M., Ferrari, A., Bisogno, G., Cecchetto, G., Basso, E., De Bernardi, B., et al. (2000) Alveolar Soft Part Sarcoma in Children and Adolescents: A Report from the Soft-Tissue Sarcoma Italian Cooperative Group. Annals of Oncology, 11, 1445-1449. https://doi.org/10.1023/A:1026579623136</mixed-citation></ref></ref-list></back></article>